Evidence-Based Complementary and Alternative Medicine

Research Article

[Retracted] The Effect of Renal Denervation on Cardiac Diastolic Function in Patients with Hypertension and Paroxysmal Atrial Fibrillation

Table 1

Patient characteristics.
Detection indexesPatients (n = 190)
Age, y53.21 ± 7.38
Male, n (%)104 (54.73)
Currently smoking, n (%)9 (4.73)
BMI (kg/m2)24.33 ± 2.57
SBP (mmHg)156.38 ± 11.36
DBP (mmHg)99.55 ± 9.71
HR (bpm)94.33 ± 5.63
Comorbidities, n (%)
 Respiratory diseases2 (1.05)
 Diabetes7 (3.68)
 Cerebrovascular disease5 (2.63)
 Renal insufficiency4 (2.11)
 Dyslipidemia5 (2.63)
Medications, n (%)
 ACEIs/ARBs126 (66.32)
 Beta-blockers163 (85.79)
 Calcium-channel blockers133 (70.00)
 Diuretics190 (100.00)
 Amiodarone32 (16.84)
 Propafenone10 (5.26)
 Warfarin21 (11.05)
 NOACs145 (76.32)
BMI: body mass index. Respiratory diseases include chronic bronchitis, emphysema, chronic obstructive pulmonary disease, asthma, and moderate and severe pulmonary hypertension. Cerebrovascular disease is defined as a history of stroke, cerebral hemorrhage, carotid artery stent, or angioplasty. Renal insufficiency is defined as serum creatinine eGFR <60 mL/min/1.73 m2. Dyslipidemia is defined as previous dyslipidemia or a history of anti-lipid medication. ACEIs/ARBs: angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers; NOACs: novel oral anticoagulants.